Ken Griffin Merck & Co., Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Merck & Co., Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 5,417,400 shares of MRK stock, worth $417 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
5,417,400
Previous 3,872,600
39.89%
Holding current value
$417 Million
Previous $385 Million
26.22%
% of portfolio
0.1%
Previous 0.07%
Shares
31 transactions
Others Institutions Holding MRK
# of Institutions
3,891Shares Held
1.93BCall Options Held
26.2MPut Options Held
23.5M-
Vanguard Group Inc Valley Forge, PA253MShares$19.4 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.28 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.29 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.59 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $195B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...